The APOE ε2 and ε4 variants have previously been associated with a decreased (ε2) or increased (ε4) risk for several age-related diseases, such as CVDs and Alzheimer’s disease (AD), which could explain the APOE effect on longevity [29,38,39,41,42]. Here, APOE is linked to early-onset autosomal dominant Alzheimer disease.